Pharma & Biotech

Swiss pharmaceutical services provider Lonza has delivered exceptional first-half 2025 results, prompting upward revisions to its annual forecasts. The company's...

As the healthcare sector continues to grapple with the opioid crisis, Pacira BioSciences has positioned itself as a dedicated provider...

French vaccine developer Valneva faces a significant crisis after US regulators delivered a stunning blow. The Food and Drug Administration...

Wall Street has found its newest compelling narrative in Arcellx, a clinical-stage therapy developer commanding significant attention. As the company...

The chapter closes on Walgreens Boots Alliance's nearly 98-year history as a publicly traded entity, following the finalization of its...

Medical technology leader Stryker has introduced its latest innovation, the Incompass™ Total Ankle System, targeting the complete ankle replacement market....

The biotechnology sector thrives on breakthrough moments, yet Fate Therapeutics continues to keep its investors anticipating that pivotal event. As...

The inclusion of Modeyso (dordaviprone) in the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines represents a significant validation for...

The landscape for mRNA therapeutics has transformed dramatically since the pandemic era. Two German pioneers in this revolutionary field now...

The investment narrative for Vigil Neuroscience is now singularly focused on its impending acquisition by pharmaceutical titan Sanofi. The biotech...